Department of Infectious Disease and Infection Control, Saitama Medical University, 38 Morohongo, Moroyama-machi, Iruma-gun, Saitama, 350-0495, Japan.
Center for Clinical Infectious Diseases and Research, Saitama Medical University, 38 Morohongo, Moroyama-machi, Iruma-gun, Saitama, 350-0495, Japan.
BMC Infect Dis. 2019 Nov 8;19(1):946. doi: 10.1186/s12879-019-4498-x.
Klebsiella variicola and K. quasipneumoniae are new species distinguishable from K. pneumoniae but they are often misidentified as K. pneumoniae in clinical settings. Several reports have demonstrated the possibility that the virulence factors and clinical features differ among these three phylogroups. In this study, we aimed to clarify whether there were differences in clinical and bacterial features between the three phylogroups isolated from patients with bloodstream infections (BSIs) in Japan.
Isolates from all patients with BSIs caused by K. pneumoniae admitted to two hospitals between 2014 and 2017 (n = 119) were included in the study. Bacterial species were identified via sequence analysis, and their virulence factors and serotypes were analyzed via multiplex PCR results. Clinical data were retrieved from medical records.
Of the 119 isolates, 21 (17.7%) were identified as K. variicola and 11 (9.2%) as K. quasipneumoniae; K1 serotype was found in 16 (13.4%), and K2 serotype in 13 (10.9%). Significant differences in the prevalence of rmpA, iutA, ybtS, entB and kfu (p < 0.001), and allS genes (p < 0.05) were found between the three phylogroups. However, there were no significant differences in clinical features, including the 30-day mortality rate, between the three organisms, although K. variicola was more frequently detected in patients over 80 years old compared with other Klebsiella species (p < 0.005), and K. quasipneumoniae more frequently occurred in patients with malignancy (p < 0.05).
Our findings demonstrated the differences in bacterial pathogenicity and clinical features among these three phylogroups. Further epidemiological studies into BSI caused by Klebsiella species are warranted.
产酸克雷伯菌和肺炎克雷伯菌是可从肺炎克雷伯菌中区分出来的新物种,但在临床环境中常被错误鉴定为肺炎克雷伯菌。有几项报告表明,这三个进化枝的毒力因子和临床特征可能存在差异。在这项研究中,我们旨在阐明从日本血流感染(BSI)患者中分离的这三个进化枝在临床和细菌特征方面是否存在差异。
纳入了 2014 年至 2017 年期间两家医院收治的由肺炎克雷伯菌引起的所有 BSI 患者的分离株(n=119)。通过序列分析鉴定细菌种类,并通过多重 PCR 结果分析其毒力因子和血清型。从病历中检索临床数据。
在 119 株分离株中,21 株(17.7%)鉴定为产酸克雷伯菌,11 株(9.2%)鉴定为肺炎克雷伯菌;16 株(13.4%)为 K1 血清型,13 株(10.9%)为 K2 血清型。在 rmpA、iutA、ybtS、entB 和 kfu(p<0.001)以及 allS 基因(p<0.05)的流行率方面,三个进化枝之间存在显著差异。然而,三个生物体之间的临床特征,包括 30 天死亡率,没有显著差异,尽管产酸克雷伯菌在 80 岁以上的患者中比其他克雷伯菌更常见(p<0.005),肺炎克雷伯菌在恶性肿瘤患者中更常见(p<0.05)。
我们的研究结果表明了这三个进化枝在细菌致病性和临床特征方面的差异。需要进一步开展有关克雷伯菌属引起的 BSI 的流行病学研究。